Alivus Life Sciences Share Price Falling Today: Stock Drops 2.71% to Rs 1,132.60 on 17 July 2026
- July 17, 2026
- Posted by: Ankit Jaiswal
- Category: News
Alivus Life Sciences share price falling today, down 2.71% to Rs 1,132.60. Day range Rs 1,111.20 to Rs 1,170.40. Volume 41,854.
The Alivus Life Sciences share price is falling today, down 2.71% to Rs 1,132.60 on the NSE in trade on 17 July 2026, as Alivus Life Sciences features among the top losers in the broader market. The stock opened at Rs 1,164.90 against the previous close of Rs 1,164.10 and has moved between a low of Rs 1,111.20 and a high of Rs 1,170.40 during the session.
Trading volumes have been elevated, with around 41,854 shares changing hands, reflecting strong participation behind today’s move. Alivus Life Sciences’ decline today comes amid mixed sentiment across pharmaceutical and API linked stocks in the session.
Click Here – Get Free Investment Predictions
Alivus Life Sciences Share Price Falling Today: Trading Snapshot
The table below summarises the Alivus Life Sciences share price action as of the latest trade on 17 July 2026.
| Parameter | Value |
|---|---|
| CMP | Rs 1,132.60 |
| Change | -2.71% |
| Day Open | Rs 1,164.90 |
| Day High | Rs 1,170.40 |
| Day Low | Rs 1,111.20 |
| Previous Close | Rs 1,164.10 |
| Volume | 41,854 shares |
Prices and volumes are from trade on 17 July 2026 and will keep changing through the session. The Alivus Life Sciences share price falling today against this kind of elevated volume base typically signals more than routine day to day trading interest.
Consult a SEBI-Registered Investment Advisor at Univest
Why the Alivus Life Sciences Share Price Is Falling Today
Alivus Life Sciences, formerly Glenmark Life Sciences, an active pharmaceutical ingredients manufacturer, is down 2.71 percent today amid broader profit booking in pharmaceutical and specialty chemical stocks. The company manufactures APIs used in a range of therapeutic categories, supplying both domestic formulators and export markets.
API and specialty pharma manufacturing stocks have periodically seen volatility this year tied to raw material cost trends, export demand fluctuations, and regulatory developments in key markets like the United States and Europe. No specific negative company announcement was identified at the time of writing, suggesting today’s move reflects broader sector sentiment.
About Alivus Life Sciences
Alivus Life Sciences is an active pharmaceutical ingredients manufacturer, producing APIs across cardiovascular, diabetes, pain management, and other therapeutic categories for domestic and export pharmaceutical markets.
Alivus Life Sciences Share Price Falling Today: What Should Investors Watch
Investors should watch export demand trends, particularly from the US and European markets, raw material and input cost trends affecting margins, and upcoming quarterly results for confirmation of underlying business momentum.
Investors should avoid chasing the Alivus Life Sciences share price purely because it is falling today, and instead evaluate whether the underlying business rationale supports the move before making any investment decision.
Download the Univest iOS App or Univest Android App to track the Alivus Life Sciences share price live and get daily stock research.
Conclusion
The Alivus Life Sciences share price is falling today, down 2.71% to Rs 1,132.60 on 17 July 2026, with volumes well above typical levels. Broader profit booking across pharmaceutical and API linked stocks appears to be weighing on the counter today. Investors should track further developments and consult a SEBI-registered advisor before making investment decisions based on the Alivus Life Sciences share price falling today.
Volumes in the first half of the trading session are often the heaviest on days with sharp stock specific moves, before activity moderates into the close.
Investors should also check whether peer stocks in the same sector are moving in tandem, which can indicate a broader theme rather than a stock specific development.
Quarterly results, management commentary, and sector data released in the coming weeks will offer more clarity on whether today’s strength is likely to hold.
Momentum traders watching the Alivus Life Sciences share price falling today often use volume confirmation, like today’s elevated turnover, as a signal that the move has genuine participation behind it rather than being a thin, low-volume spike.
Volumes in the first half of the trading session are often the heaviest on days with sharp stock specific moves, before activity moderates into the close.
Analysts typically wait for a day or two of follow-through before treating a single session’s rise in the Alivus Life Sciences share price as the start of a sustained trend rather than a one-off event.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions FAQs
Why is the Alivus Life Sciences share price falling today?
Ans. The Alivus Life Sciences share price is falling today, down 2.71% to Rs 1,132.60 on 17 July 2026. Alivus Life Sciences is down 2.71 percent today amid broader profit booking in pharmaceutical and specialty chemical stocks, without a specific negative company development identified.
What is the Alivus Life Sciences share price today?
Ans. The Alivus Life Sciences share price is trading at Rs 1,132.60 on the NSE on 17 July 2026, down 2.71% from the previous close of Rs 1,164.10, with the stock moving between Rs 1,111.20 and Rs 1,170.40 during the session.
How much trading volume has Alivus Life Sciences seen today?
Ans. Alivus Life Sciences has traded with volumes of around 41,854 shares so far today, reflecting elevated participation compared to typical sessions.
What does Alivus Life Sciences do?
Ans. Alivus Life Sciences, formerly Glenmark Life Sciences, is an active pharmaceutical ingredients manufacturer serving domestic and export pharmaceutical markets.
Is the Alivus Life Sciences share price falling today a buying signal?
Ans. A single day’s rise is not a reliable buying signal on its own. Evaluate the underlying business rationale, valuations, and your own risk appetite before making any investment decision, and consult a SEBI-registered advisor.
What should investors watch for the Alivus Life Sciences share price?
Ans. Watch export demand trends from the US and Europe, input cost trends affecting margins, and upcoming quarterly results.
Where can I track the Alivus Life Sciences share price live?
Ans. You can track the Alivus Life Sciences share price live on NSE and BSE, or on the Univest app, which also provides daily research and market updates on Indian stocks.
